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Summary
Subliminal visual stimuli affect motor planning [1], but the
size of such effects differs greatly between individuals
[2, 3]. Here, we investigated whether such variation may be
related to neurochemical differences between people.
Cortical responsiveness is expected to be lower under the
influence of more of the main inhibitory neurotransmitter,
GABA [4]. Thus, we hypothesized that, if an individual has
more GABA in the supplementary motor area (SMA)—a
region previously associated with automatic motor control
[5]—this would result in smaller subliminal effects. We
measured the reversed masked prime—or negative compat-
ibility—effect, and found that it correlated strongly with
GABA concentration, measured with magnetic resonance
spectroscopy. This occurred specifically in the SMA region,
and not in other regions from which spectroscopy measure-
ments were taken. We replicated these results in an inde-
pendent cohort: more GABA in the SMA region is reliably
associated with smaller effect size. These findings suggest
that, across individuals, the responsiveness of subcon-
scious motor mechanisms is related to GABA concentration
in the SMA.
Results and Discussion
Differences between people have long been studied at the
level of personality or intelligence, but people also differ in
much more basic neural processes, even ones that are
subconscious and automatic (e.g., Figure 7 in [2], Figure 5 in
[3]). In the study of such low-level phenomena, behavior
across a group of individuals is usually averaged, and differ-
ences are treated as unwanted noise (random variation).
However, this approach overlooks the inescapable fact that
a component of the measured differences may reflect stable
individual traits, no matter how low level the mechanism
(see Figure S1 available online). Such basic traits may also
hold essential clues into how individual differences translate
into mental disorders. To our knowledge, no explanation has
ever been provided for individual differences in automatic
mechanisms operating at the threshold of conscious aware-
ness, even though they potentially offer a cleaner index than*Correspondence: sumnerp@cardiff.ac.ukmeasures of conscious behavior. Recent advances in
magnetic resonance spectroscopy (MRS) allow us to ask
whether these traits might be predicted by differences in
neurotransmitter concentration in specific brain regions
[6–13].
We studied reversed masked priming by using a standard
paradigm [14, 15]. Participants must respond to arrows point-
ing left or right by pressing different buttons, and each target
arrow is preceded by a very brief and backward-masked prime
arrow (Figure 1A). Prior to the main priming procedure, the
primes were set to be below the threshold of conscious
perception determined for each participant by using a stair-
case discrimination task. Nevertheless, these prime stimuli
influenced responses to the target arrows.
When the time between prime and target was very short,
responses were facilitated by primes pointing in the same
direction as targets (mean, 21 ms; p < 0.017). This is known
as the positive compatibility effect (PCE), and is taken as an
index of subliminal activation by the prime [1]. However,
when the target was presented slightly later, responses were
relatively delayed for targets pointing in the same direction
as primes (mean 26 ms; p < 0.008). This reversed masked
prime effect is known as the negative compatibility effect
(NCE), and is taken as an index of an automatic inhibitory
mechanism that is triggered to suppress the initial subliminal
motor activation evoked by the primes [16–19]. Importantly
for our study, this mechanism has been linked with a specific
brain area, the supplementary motor area (SMA): the NCE
has been reported absent in patients with very specific lesions
in this region [5], and in healthy participants, the behavioral
NCE is accompanied by fMRI modulation in the SMA [20].
Participants varied considerably in the size of their NCE
(range, 245 to 28 ms), and this is a robust trait: we found
a high correlation between measurements taken in the same
person several weeks apart (Figure S1). We tested whether
this individual variation is correlated with subtle differences
in resting brain chemistry in the SMA. Neuronal activity in all
cortical regions reflects a complex interplay between excit-
atory and inhibitory synapses. The latter mainly employ the
neurotransmitter gamma-aminobutyric acid (GABA), and we
predicted, therefore, that the size of the NCE might be related
to the level of GABA concentration in the SMA, given that the
SMA is thought to play an important role in the NCE [5, 20].
Furthermore, opposing predictions can be made depending
on the exact role of the SMA: if the main role of the SMA in
reversed priming is to be the site of inhibition, then we would
predict that more GABAwould be associated with more inhibi-
tion, and thus a larger NCE. If, on the other hand, the SMA is
more involved upstream, with eliciting the inhibition process,
we would predict smaller NCEs in those participants with
higher GABA concentration in the SMA, because more
GABAergic inhibition within a region would make that region
less responsive [4] (for example, the GABA agonist muscimol
is commonly used to temporarily deactivate a region in animal
research, e.g., [21]).
Using edited MR spectroscopy [6, 8], we measured GABA
concentration from a (3 cm)3 region of dorsal medial frontal
cortex, including, but not limited to, both right and left SMA
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Figure 1. Methodology for Masked Priming and GABA Spectroscopy
(A) Target arrows were preceded by masked primes presented below the threshold for conscious discrimination. For the stimulus timing illustrated,
responses tend to be slower when prime and target are the same (compatible) than when they are not (right-hand illustration). This is the measure of sublim-
inal suppression, and the magnitude differs between individuals.
(B) TheMRS voxel (yellow, [3 cm]3 voxel) was placed over the anatomical location of SMA. As a check on voxel placement, for two participants, we acquired
a functional localizer for the SMA by using fMRI (see Experimental Procedures and bottom sagital view).
(C) EditedMR spectra allow the quantification of GABA concentration by extracting the area under the GABApeak [6, 8, 9, 49] (glutamine/glutamate, Glx, and
N-acetyl-aspartate, NAA, peaks are also marked). The peak will also contain coedited macromolecules. See Experimental Procedures and Figure S2 for
more details and individual spectra.
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1780(we refer to this as the SMA region [Figures 1B and 1C]; see
Figure S2 for individual GABA peaks within the spectra). This
correlated well with the magnitude of the NCE, such that
participants with higher GABA concentration in this region
had smaller NCEs (r = 0.77; p < 0.005 uncorrected; n = 12; boot-
strap 95% confidence interval, r = 0.51–0.93 [Figure 2A, left]).
We replicated this result in a separate cohort of 13 subjects
(r = 0.62; p = 0.025; bootstrap 95% confidence interval,
r = 0.11–0.85 [Figure 2A, right]). In both groups, therefore, the
magnitude of the NCE was inversely related to GABA concen-
tration in SMA.
In the same participants, we also measured GABA concen-
tration in other regions that have been associatedwith control-
ling the interaction between visual stimuli and action plans:
dorsolateral prefrontal cortex, parietal cortex (both cohorts),anterior cingulate, and inferior frontal gyrus (first cohort)
[22–25]. In these regions, GABA concentration did not corre-
late with the NCE (Figure 2B; see also Figure S3). Thus, our
data show regional specificity for the relationship between
GABA and subconscious motor suppression.
We also found that the NCE correlates behaviorally with
positive priming (the PCE, first cohort, r = 20.8, p < 0.005;
second cohort, r = 20.5, p < 0.05 one-tailed [Figures 3A
and 3B]). People with smaller NCEs tend also to have smaller
PCEs, which rules out the possibility that smaller NCEs simply
reflected difficulty in overturning large initial positive priming
phases. Rather, it suggests that, in some people, both mech-
anisms are less responsive. However, GABA in the SMA region
does not significantly correlate with the PCE (Figures 3C
and 3D), and, thus, the association between PCE and NCE
AB
Figure 2. Subliminal Suppression Correlates with GABA in the SMA Region
Higher GABA concentration in the region around human SMA predicts smaller NCE across individuals (A). This result was replicated in a second cohort
(right). (B) There was no correlation between the NCE and GABA concentration in dorsolateral prefrontal cortex (DLPFC), parietal cortex, anterior cingulate
cortex (ACC), or inferior frontal gyrus (IFG). Positioning of these MRS voxels is shown for one participant (yellow rectangles on inset brains). Note that,
although the word cortex is included in some labels (to follow standard abbreviations for these regions), all voxels necessarily included both gray and white
matter. Filled symbols and bold R values reflect measurements from the second cohort. GABA concentration measurements are stated in institutional units
(i.u.). All p values are given two-tailed, but uncorrected for multiple comparisons; the main relationship of interest between the NCE and the SMA was spec-
ified a priori [5], but even if it had not been (and the first p value is corrected), the replication demonstrates that the relationship is robust.
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1781must arise elsewhere. This is consistent with previous
research, in which lesions in the locality of the SMA disrupted
the NCE, but a PCE was present [5].
We tested whether the correlation between the NCE and
GABA in the SMA region might arise due to other individual
factors: age, prime visibility, overall speed of responding,
error rate, and gray matter volume. It did not; there were no
significant correlations of either the NCE or GABA in SMA
with any of these factors, and, when controlling for them, the
correlation between SMA GABA and the NCE remained
(Figure 4).
What, then, is the cause of the relationship between
a person’s NCE and GABA in their SMA region? The direction
of the relationship implies that SMA is involved in the produc-
tion of suppression rather than being the site where it occurs.
The intuitive expectation might be that more GABA is associ-
atedwithmore inhibition, and, thus, a larger NCE. This relation-
ship would be consistent with suppression within the SMA.
However, directional expectations are complicated, because
the SMA is part of a network with other regions. If it is involved
upstream, in the eliciting of inhibition rather than theimplementation of inhibition, then lowering the responsiveness
of this region with more baseline GABA would be predicted to
lessen its functional effect, reducing the NCE.
The latter prediction is consistent with the deactivating
effect of GABA agonist muscimol, and also with the absence
of the NCE in patients in which the area is deactivated by
actual lesions [5]. It is also consistent with two MRS studies
measuring GABA in primary motor cortex: lowered cortical
excitability following theta burst stimulation was associated
with increased GABA concentration [4], and motor learning,
which is thought to increase cortical excitability, was associ-
ated with lower GABA levels [26]. Thus, the direction of corre-
lation we found suggests that GABA levels in the SMA have
a greater influence on the production of the suppression
process creating the NCE than its implementation. The site
of inhibition may be basal ganglia [27].
The relationship does not reflect general differences in
caution or arousal, because neither the NCE nor SMA GABA
correlated with overall speed or accuracy (Figure 4). Nor is it
explained by any factor common to all sensorimotor tasks
containing elements of response compatibility, conflict, or
A B
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Figure 3. Correlations of the PCE with the NCE and GABA in the SMA
(A and B) Higher PCE (subliminal activation) predicts higher (more negative) NCE (subliminal suppression). Further analyses of previously published data [3]
also revealed strong correlations between NCE and PCE (experiment 1, r =20.69 [p < 0.013]; experiment 2, r =20.72 [p < 0.008]; and experiment 3, r =20.63
[p < 0.03]). Thus, it seems a general and robust phenomenon that the magnitudes of the PCE and NCE are correlated across individuals. However, although
there is weak correlation in both cohorts between the PCE and GABA concentration in the SMA region (C and D), this was not significant (even across
cohorts), and is presumably just mediated by the correlations between NCE andGABA and between NCE and PCE. Thus, it appears that the common factor
between NCE and PCE does not lie with GABA in the SMA.
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1782inhibition, because neither SMA GABA nor the NCE correlated
with other tasks that we have measured, including the Simon
task [28], the Eriksen flanker task [29], and the STOP task
[30] (Figure S4).
In the Simon task [28], participants made left or right
responses to the identity of letters appearing on the left or right
of fixation. The location of the letter is irrelevant, but there is an
automatic spatial compatibility effect such that responses
tend to be faster when the stimulus appears on the same
side as the required response. The fact that this ‘‘Simon effect’’
does not correlate behaviorally with the NCE (or PCE), or with
GABA in the SMA region, indicates that individual differences
in these two phenomena reflect dissociable traits. Similarly,
in the Eriksen flanker task [29], participants respond to a
central arrow, which is flanked by irrelevant arrows that also
cause a compatibility effect: responses tend to be faster
when the flankers point in the same direction as the target.
Although recent evidence suggests some shared mechanism
between subliminal suppression and the control of flanker
interference [31], individual differences in the flanker effect
appear dissociable from individual differences in the NCE,
and do not reflect SMA GABA concentration.In the STOP task [30, 32], participants made speeded button
presses to a shape cue, but, on a subset of trials, a second
stimulus was presented that instructed them to withhold their
response. The interval between go and stop signals is modu-
lated to find the interval at which participants successfully
stop on 50% of the stop trials. This ‘‘stop signal reaction
time’’ varied between participants, but, importantly, did not
correlate with the NCE or with GABA in the SMA region.
Thus, we find some specificity in the relationship between
SMA GABA and functional inhibitory mechanisms, but this is
not to say that SMA GABA only influences the NCE. In general,
we argue that control of specific functions will be subject to
influence by the GABA level in areas of the brain that are caus-
ally involved in that function. Thus, GABA concentration in
SMA presumably affects other functions for which SMA plays
a critical role.
It is not yet known why natural differences in baseline GABA
concentration occur, and what factors create their regional
specificity (Figure S3; see also [33]). The differences in MRS
signal that we measured probably reflect different densities
of GABA interneurons or synapses. Abnormalities in
GABAergic inhibition have been associated with a number of
A B C
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Figure 4. GABA in SMA Region Does Not Correlate with Other Potential Mediating Factors
(A) shows age, (B) shows prime identification, (C) showsmean reaction time, (D) shows error rate, (E) shows error compatibility effect, and (F) shows fraction
of GM in SMA MRS voxel. R values are the correlation coefficient obtained putting both cohorts together; R1 and R2 values are the coefficient obtained for
cohort 1 and 2 separately. Therewas also no significant correlation of any of these factorswith the NCE (all jRj, jR1j, or jR2j < 0.44; p > 0.16). Most importantly,
when these factors were controlled for, the (partial) correlation (Rp) between the NCE and GABA in the SMA region remained. When controlling for the
amount of gray matter (GM), R1p = 0.8 (p < 0.003) and R2p = 0.53 (p < 0.04) (one-tailed). Similarly, when controlling for age, R1p = 0.77 (p < 0.005), R2p =
0.62 (p < 0.035); for average speed, R1p = 0.84 (p < 0.001), R2p = 0.61 (p < 0.03); for prime visibility, R1p = 0.8 (p < 0.003), R2p = 0.55 (p < 0.03) (one-tailed);
and for error rate, R1p = 0.75 (p < 0.008), R2p = 0.51 (p < 0.045) (one-tailed). Note that, as a neurotransmitter, the concentration of GABA is expected to be
higher in GM than in white matter, so one might predict a correlation between GM volume and GABA. However, the GM proportion in the voxel was very
similar across participants (i.e., it was well controlled for), so there was little opportunity for a correlation to be revealed. GM proportion ranged from
49% to 54% in cohort 1, and from 46% to 55% in cohort 2. The essential point is not whether GM correlates with GABA, but that this relationship does
not account for the correlation of GABA with the NCE.
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1783clinical conditions, including schizophrenia, epilepsy, atten-
tion deficit/hyperactivity disorder, obsessive-compulsive
disorder, depression, and bipolar disorder [34–40], but the
relationship between symptoms and pathophysiology remains
little understood.
The ability to relate specific and even subconscious traits to
GABA in specific brain regions in healthy individuals promises
to inform the study of such disorders, where there is no clear
division between healthy and clinical populations. Moreover,
our finding that differences in GABA concentration are region-
ally specific (as opposed to globally correlated) underlines the
importance of targeting specific brain regions in clinical GABA
MRS studies [41, 42], rather than inferring global changes from
measurements of one region [43, 44].
In sum, we have found that individual variation in an auto-
matic motor mechanism operating at the threshold of
conscious awareness is reliably correlatedwithGABA concen-
tration specifically in a region of medial frontal cortex, but not
in other frontal regions or parietal cortex. This result promises
that we can begin to understand differences in people’s basic
behavior in terms of the neurochemistry of specific brain
regions.Experimental Procedures
Overview
In the first experiment, we acquired (over two MR sessions per participant)
MRS measurements from a (3 cm)3 voxel around the SMA, as well as an
anatomical MRI scan and further MRS measurements from voxels in the
parietal lobe, dorsolateral prefrontal cortex (DLPFC), inferior frontal gyrus
(IFG), and the anterior cingulate cortex (ACC). Note that, in MRS, we acquire
an average spectrum from a single predefined volume (it is not an imaging-
like technique), and, thus, measurements for each volume were taken sepa-
rately (12 min each). On a separate occasion (not in the scanner), each
participant was tested in the masked priming tasks, Simon task, Eriksen
flanker task, and STOP task.
The aim of the second experiment was simply to test, in a second, inde-
pendent, cohort, the robustness of the relationship found between GABA
and behavior in the first experiment. There was one MR session per partic-
ipant, consisting of an anatomical MRI scan followed by three MRS
measurements from voxels in the SMA region, DLPFC, and parietal cortex.
On a separate occasion, each participant was tested in the masked priming
tasks and Simon task.Participants
For the first experiment, 12 volunteers (all male, aged 21–32 years) were
recruited within the School of Psychology, Cardiff University. For the
second experiment, 13 volunteers were similarly recruited (all male, aged
Current Biology Vol 20 No 19
178419–35 years). All had normal or corrected-to-normal vision, no neurological
history, and received payment for their time. All were naive to the purpose of
the study. The local ethics committee approved all procedures.
Anatomical MRI
A 1 mm3 isotropic resolution, T1-weighted anatomical MRI scan (FSPGR)
was carried out to allowMRS voxel placement, and subsequent reconstruc-
tion of the cortical surface and segmentation of the MRS voxel. To segment
the volume, we used both FAST (http://www.fmrib.ox.ac.uk/fsl/) and Free-
Surfer (http://surfer.nmr.mgh.harvard.edu/), and these methods showed
a high degree of correlation for gray matter volume (r > 0.95). In the reported
results, gray matter estimates came from FreeSurfer.
MRS
In both experiments, GABA-edited MEGA-PRESS spectra [6, 8] were
acquired from voxels positioned according to anatomical landmarks. The
SMA voxel was placed symmetrically over the midline with its backward
face anterior to the central sulci. All voxels, except in the ACC, were
(3 cm)3, with one face of the cube aligned with the cortical surface. The
ACC voxel was 23 33 4 cm3 in order to restrict it mainly to the appropriate
region. The order of MRS voxels was counterbalanced across participants.
Note that the MRS voxel is chosen a priori, and must be large enough to
ensure sufficient signal quality to investigate individual differences in
GABA concentration. Each MRS measurement was preceded by several
brief anatomical imaging acquisitions in different orientations to allow accu-
rate voxel placement.
The field strength was 3 Tesla, and the following experimental parameters
were used: echo time (TE) = 68 ms; repetition time (TR) = 1800 ms; 400 tran-
sients of 4096 data points were acquired in 12 min; 16 ms Gaussian editing
pulses were applied either to the GABA spins at 1.9 ppm or at 7.5 ppm in an
interleaved manner. Phased-array coil data were combined (using the first
point of the unsuppressed water-free induction decay signal), and spectra
were processed by locally written software. Three hertz exponential line
broadening and a high-pass water filter were applied, and the MEGA-
PRESS difference spectrum was produced. The edited GABA signal at
3 ppm and the unsuppressed PRESS water signal were integrated: the inte-
gral of the GABA peak was calculated automatically by using a linear fit of
the baseline and a Gaussian fit to the peak itself (Figure S2); the water signal
was fitted with a Lorentzian-Gaussian lineshape [45]. The GABA-fitted
amplitude was scaled to account for the fraction of cerebrospinal fluid
(CSF) within the voxel, and the water amplitude was scaled to account for
the different water content in CSF and gray and white matter [46]. A concen-
tration measurement in institutional units was derived from the ratio of the
GABA andwater signals by using a single scalar to adjust for the editing effi-
ciency and the T1 and T2 relaxation times of water and GABA. The GABA
peak will also contain signal from coedited macromolecules (e.g., cytosol),
and this may contribute 30%–40% of the integrated area [47]. However, we
have no reason to expect that these would differ between individuals or
have an influence on sensorimotor behavior. Confidence that individual
differences in our measure of GABA concentration reflect actual GABA
differences can be drawn from recently reported association of this
measurement with gamma frequency, BOLD signal, transcranial magnetic
stimulation, and sensory tuning, all of which are well modeled by variation
in GABA [4, 10–12, 48].
Functional Localizer
As a check on the placement of our main voxel of interest, for two partici-
pants we acquired a functional localizer for the SMA by using fMRI. A stan-
dard boxcar protocol was used with 15 s of sequential finger movements
and 15 s of rest. We used a gradient echo EPI sequence taking 26 oblique-
axial slices at 3 mm isotropic voxel resolution; 265 T2*-weighted volumes
(TR = 1500 ms, TE = 35 ms, 90 flip angle, acquisition matrix = 64 3 64).
Due to time constraints, this could not be done for all participants in the
MRS sessions.
Masked Priming
Stimulus presentation was performed by a PC-controlled Cambridge
Research Systems (CRS) Visage connected to a 21 inch Sony GDM-F520
Trinitron monitor. Stimulus presentation was synchronized with the screen
refresh rate of 100 Hz, and timing was controlled and measured by the CRS
clock and thus not subject to the errors produced by normal PC operating
systems. Manual responses were collected with a CRS CB6 button box.
Participants had tomake speeded responseswith a left- or right-hand key
press to left/right arrows (1 3 1), which occurred in random order andwithin 4 of fixation. A fixation cross was visible at the center of the screen
at the beginning of each trial. The primes were identical to either one or the
other targets, but presented for a briefer duration determined by prior adap-
tive staircase procedure (described below), and appeared within 0.3 of
fixation. In all conditions, the prime was immediately followed by a mask
of 2 3 2, presented for 100 ms and constructed of 35 randomly orientated
lines, excluding any orientation closer than 5 to the orientations in the arrow
stimuli. A new mask was constructed on each trial.
To be sure that the masked-prime stimuli were subliminal at the start of
the priming blocks, we used a psychophysical adaptive staircase procedure
to determine the presentation duration for which an individual could
consciously report the direction of the prime (for similar method, see [19]).
Note that, although we did not measure prime visibility again after the
main task, the settings we used were similar to studies in which we have
measured visibility afterwards, and, in our experience, prime discrimina-
bility does not grow during priming blocks (in which the participant is
ignoring the prime). To measure the NCE, we set the delay between prime
offset and target onset to 150 ms. To measure the PCE, we set this delay
to 40 ms. A control experiment, as well as previous work, found these
timings to provide robust and approximately maximal PCE and NCE effects
[3]. There were 400 trials in each block (PCE and NCE).
Several weeks (2–8) after the first measurement, we assessed the repeat-
ability of the NCE measurement by submitting participants to a further 200
trials of the samemasked prime paradigm. Details of the other tasks that we
measured can be found in the Supplemental Information.Supplemental Information
Supplemental Information includes Supplemental Experimental Procedures
and four figures and can be found with this article online at doi:10.1016/j.
cub.2010.09.003.Acknowledgments
This work was supported by the Wellcome Trust, the Wales Institute of
Cognitive Neuroscience (WICN), and the NIHR CBRC at UCL/UCLH.
CUBRIC was established with support from the UK Department of Trade
and Industry, Cardiff University, and the Welsh Assembly government. We
thank also Tracy Herlihey, Sian Griffiths, and Aline Bompas for comments
on the manuscript.
Received: June 16, 2010
Revised: June 27, 2010
Accepted: August 31, 2010
Published online: September 30, 2010References
1. Neumann, O., and Klotz, W. (1994). Motor-responses to nonreportable,
masked stimuli—where is the limit of direct parameter specification. In
Attention and Performance XV: Conscious and Nonconscious Informa-
tion Processing, C. Umilta` and M. Moscovitch, eds. (Cambridge, MA:
MIT Press), pp. 123–150.
2. Hermens, F., Sumner, P., and Walker, R. (2010). Inhibition of masked
primes as revealed by saccade curvature. Vision Res. 50, 46–56.
3. Boy, F., and Sumner, P. (2010). Tight coupling between positive and
reversed priming in the masked prime paradigm. J. Exp. Psychol.
Hum. Percept. Perform. 36, 892–905.
4. Stagg, C.J., Wylezinska, M., Matthews, P.M., Johansen-Berg, H.,
Jezzard, P., Rothwell, J.C., and Bestmann, S. (2009). Neurochemical
effects of theta burst stimulation as assessed by magnetic resonance
spectroscopy. J. Neurophysiol. 101, 2872–2877.
5. Sumner, P., Nachev, P., Morris, P., Jackson, S.R., Kennard, C., and
Husain, M. (2007). Human medial frontal cortex mediates unconscious
inhibition of voluntary action. Neuron 54, 697–711.
6. Mescher, M., Merkle, H., Kirsch, J., Garwood, M., and Gruetter, R.
(1998). Simultaneous in vivo spectral editing and water suppression.
NMR Biomed. 11, 266–272.
7. Northoff, G., Walter, M., Schulte, R.F., Beck, J., Dydak, U., Henning, A.,
Boeker, H., Grimm, S., and Boesiger, P. (2007). GABA concentrations in
the human anterior cingulate cortex predict negative BOLD responses
in fMRI. Nat. Neurosci. 10, 1515–1517.
Subliminal Priming and GABA
17858. Edden, R.A., and Barker, P.B. (2007). Spatial effects in the detection of
gamma-aminobutyric acid: Improved sensitivity at high fields using
inner volume saturation. Magn. Reson. Med. 58, 1276–1282.
9. Kaiser, L.G., Young, K., Meyerhoff, D.J., Mueller, S.G., andMatson, G.B.
(2008). A detailed analysis of localized J-difference GABA editing:
Theoretical and experimental study at 4 T. NMR Biomed. 21, 22–32.
10. Muthukumaraswamy, S.D., Edden, R.A.E., Jones, D.K., Swettenham,
J.B., and Singh, K.D. (2009). Resting GABA concentration predicts
peak gamma frequency and fMRI amplitude in response to visual
stimulation in humans. Proc. Natl. Acad. Sci. USA 106, 8356–8361.
11. Edden, R.A., Muthukumaraswamy, S.D., Freeman, T.C., and Singh, K.D.
(2009). Orientation discrimination performance is predicted by GABA
concentration and gamma oscillation frequency in human primary visual
cortex. J. Neurosci. 29, 15721–15726.
12. Yoon, J.H., Maddock, R.J., Rokem, A., Silver, M.A., Minzenberg, M.J.,
Ragland, J.D., and Carter, C.S. (2010). GABA concentration is reduced
in visual cortex in schizophrenia and correlates with orientation-specific
surround suppression. J. Neurosci. 30, 3777–3781.
13. Sumner, P., Edden, R.A., Bompas, A., Evans, C.J., and Singh, K.D.
(2010). More GABA, less distraction: A neurochemical predictor of
motor decision speed. Nat. Neurosci. 13, 825–827.
14. Eimer, M., and Schlaghecken, F. (2003). Response facilitation and
inhibition in subliminal priming. Biol. Psychol. 64, 7–26.
15. Sumner, P. (2007). Negative and positive masked-priming—implica-
tions for motor inhibition. Adv. Cogn. Psychol. 3, 317–326.
16. Schlaghecken, F., and Eimer, M. (2006). Active masks and active inhibi-
tion: A comment on Lleras and Enns (2004) and on Verleger, Jaskowski,
Aydemir, van der Lubbe, and Groen (2004). J. Exp. Psychol. Gen. 135,
484–494.
17. Sumner, P. (2008). Mask-induced priming and the negative compati-
bility effect. Exp. Psychol. 55, 133–141.
18. Jaskowski, P. (2009). Negative compatibility effect: The object-updating
hypothesis revisited. Exp. Brain Res. 193, 157–160.
19. Boy, F., Clarke, K., and Sumner, P. (2008). Mask stimulus triggers inhi-
bition in subliminal visuomotor priming. Exp. Brain Res. 190, 111–116.
20. Boy, F., Husain, M., Singh, K., and Sumner, P. Supplementary motor
area activations in unconscious inhibition of voluntary action. Exp. Brain
Res., in press. 10.1007/s00221-010-2417-x.
21. Nakamura, K., Sakai, K., and Hikosaka, O. (1999). Effects of local inacti-
vation of monkey medial frontal cortex in learning of sequential proce-
dures. J. Neurophysiol. 82, 1063–1068.
22. Aron, A.R. (2007). The neural basis of inhibition in cognitive control.
Neuroscientist 13, 214–228.
23. Egner, T., Delano, M., and Hirsch, J. (2007). Separate conflict-specific
cognitive control mechanisms in the human brain. Neuroimage 35,
940–948.
24. Cohen, J.D., Botvinick, M., and Carter, C.S. (2000). Anterior cingulate
and prefrontal cortex: Who’s in control? Nat. Neurosci. 3, 421–423.
25. Buneo, C.A., and Andersen, R.A. (2006). The posterior parietal cortex:
Sensorimotor interface for the planning and online control of visually
guided movements. Neuropsychologia 44, 2594–2606.
26. Floyer-Lea, A., Wylezinska, M., Kincses, T., and Matthews, P.M. (2006).
Rapid modulation of GABA concentration in human sensorimotor
cortex during motor learning. J. Neurophysiol. 95, 1639–1644.
27. Aron, A.R., Schlaghecken, F., Fletcher, P.C., Bullmore, E.T., Eimer, M.,
Barker, R., Sahakian, B.J., and Robbins, T.W. (2003). Inhibition of
subliminally primed responses is mediated by the caudate and thal-
amus: Evidence from functional MRI and Huntington’s disease. Brain
126, 713–723.
28. Simon, J.R., and Wolf, J.D. (1963). Choice reaction-time as a function of
angular stimulus-response correspondence and age. Ergonomics 6,
99–105.
29. Eriksen, B.A., and Eriksen, C.W. (1974). Effects of noise letters upon
identification of a target letter in a nonsearch task. Percept. Psycho-
phys. 16, 143–149.
30. Logan, G.D., Cowan, W.B., and Davis, K.A. (1984). On the ability to
inhibit simple and choice reaction time responses: A model and
a method. J. Exp. Psychol. Hum. Percept. Perform. 10, 276–291.
31. Boy, F., Husain, M., and Sumner, P. (2010). Unconscious inhibition
separates two forms of cognitive control. Proc. Natl. Acad. Sci. USA
107, 11134–11139.
32. Verbruggen, F., Logan, G.D., and Stevens, M.A. (2008). STOP IT:
Windows executable software for the stop-signal paradigm. Behav.
Res. Methods 40, 479–483.33. Grachev, I.D., and Apkarian, A.V. (2001). Aging alters regional multi-
chemical profile of the human brain: An in vivo 1H-MRS study of young
versus middle-aged subjects. J. Neurochem. 76, 582–593.
34. Akbarian, S., Kim, J.J., Potkin, S.G., Hagman, J.O., Tafazzoli, A.,
Bunney, W.E., Jr., and Jones, E.G. (1995). Gene expression for glutamic
acid decarboxylase is reduced without loss of neurons in prefrontal
cortex of schizophrenics. Arch. Gen. Psychiatry 52, 258–266.
35. Petty, F., Kramer, G.L., Dunnam, D., and Rush, A.J. (1990). Plasma
GABA in mood disorders. Psychopharmacol. Bull. 26, 157–161.
36. Lewis, D.A., Hashimoto, T., and Volk, D.W. (2005). Cortical inhibitory
neurons and schizophrenia. Nat. Rev. Neurosci. 6, 312–324.
37. Kalueff, A.V., and Nutt, D.J. (2007). Role of GABA in anxiety and depres-
sion. Depress. Anxiety 24, 495–517.
38. Zai, G., Arnold, P., Burroughs, E., Barr, C.L., Richter, M.A., and Kennedy,
J.L. (2005). Evidence for the gamma-amino-butyric acid type B receptor
1 (GABBR1) gene as a susceptibility factor in obsessive-compulsive
disorder. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 134B, 25–29.
39. Pouget, P., Wattiez, N., Rivaud-Pechoux, S., and Gaymard, B. (2009). A
fragile balance: Perturbation of GABA mediated circuit in prefrontal
cortex generates high intraindividual performance variability. PLoS
ONE 4, e5208.
40. Di Cristo, G. (2007). Development of cortical GABAergic circuits and its
implications for neurodevelopmental disorders. Clin. Genet. 72, 1–8.
41. Hasler, G., Neumeister, A., van der Veen, J.W., Tumonis, T., Bain, E.E.,
Shen, J., Drevets, W.C., and Charney, D.S. (2005). Normal prefrontal
gamma-aminobutyric acid levels in remitted depressed subjects deter-
mined by proton magnetic resonance spectroscopy. Biol. Psychiatry
58, 969–973.
42. Bhagwagar, Z., Wylezinska, M., Jezzard, P., Evans, J., Boorman, E.,
Matthews, P.M., and Cowen, P.J. (2008). Low GABA concentrations in
occipital cortex and anterior cingulate cortex in medication-free, recov-
ered depressed patients. Int. J. Neuropsychopharmacol. 11, 255–260.
43. Bhagwagar, Z., Wylezinska, M., Jezzard, P., Evans, J., Ashworth, F.,
Sule, A., Matthews, P.M., and Cowen, P.J. (2007). Reduction in occipital
cortex gamma-aminobutyric acid concentrations in medication-free
recovered unipolar depressed and bipolar subjects. Biol. Psychiatry
61, 806–812.
44. Sanacora, G., Mason, G.F., Rothman, D.L., Behar, K.L., Hyder, F.,
Petroff, O.A., Berman, R.M., Charney, D.S., and Krystal, J.H. (1999).
Reduced cortical gamma-aminobutyric acid levels in depressed
patients determined by proton magnetic resonance spectroscopy.
Arch. Gen. Psychiatry 56, 1043–1047.
45. Marshall, I., Bruce, S.D., Higinbotham, J., MacLullich, A., Wardlaw, J.M.,
Ferguson, K.J., and Seckl, J. (2000). Choice of spectroscopic lineshape
model affects metabolite peak areas and area ratios. Magn. Reson.
Med. 44, 646–649.
46. Ernst, T., Kreis, R., and Ross, B.D. (1993). Absolute quantitation of
water and metabolites in the human brain. 1. Compartments and water.
J. Magn. Reson. B. 102, 1–8.
47. Choi, C., Bhardwaj, P.P., Kalra, S., Casault, C.A., Yasmin, U.S., Allen,
P.S., and Coupland, N.J. (2007). Measurement of GABA and contami-
nants in gray and white matter in human brain in vivo. Magn. Reson.
Med. 58, 27–33.
48. Donahue, M.J., Near, J., Blicher, J.U., and Jezzard, P. (2010). Baseline
GABA concentration and fMRI response. Neuroimage 53, 392–398.
49. Evans, C.J., McGonigle, D.J., and Edden, R.A. (2010). Diurnal stability of
gamma-aminobutyric acid concentration in visual and sensorimotor
cortex. J. Magn. Reson. Imaging 31, 204–209.
